Status: current, Sufficiently defined by necessary conditions definition status. Date: 12-Apr 2023. Module: SNOMED CT United Kingdom pathology and laboratory medicine production content extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1981000237117 | IGF-2 (insulin-like growth factor 2) molar concentration in serum | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom pathology and laboratory medicine production content extension module |
| 6981000237110 | Substance concentration of insulin-like growth factor 2 in serum (observable entity) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom pathology and laboratory medicine production content extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Substance concentration of insulin-like growth factor 2 in serum (observable entity) | Is a | Observable entity | false | Inferred relationship | Existential restriction modifier | ||
| Substance concentration of insulin-like growth factor 2 in serum (observable entity) | Inheres in | Serum | true | Inferred relationship | Existential restriction modifier | 1 | |
| Substance concentration of insulin-like growth factor 2 in serum (observable entity) | Property | Substance concentration | true | Inferred relationship | Existential restriction modifier | 1 | |
| Substance concentration of insulin-like growth factor 2 in serum (observable entity) | Component | Somatomedin A | true | Inferred relationship | Existential restriction modifier | 1 | |
| Substance concentration of insulin-like growth factor 2 in serum (observable entity) | Is a | Serum clinical chemistry | true | Inferred relationship | Existential restriction modifier | ||
| Substance concentration of insulin-like growth factor 2 in serum (observable entity) | Is a | Hormone level | true | Inferred relationship | Existential restriction modifier | ||
| Substance concentration of insulin-like growth factor 2 in serum (observable entity) | Direct site | Serum specimen | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR